APM Aptorum Group Limited - Class A

Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.

$1.89
As of 11/30/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Hong Kong
Country of incorporation:  
IPO date:  10/10/2000
Outstanding shares:  13,189,010
Average volume:  131,595
Market cap:   $25,191,009
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.54
PB ratio:   2.08
PS ratio:   21.17
Return on equity:   -79.00%
Net income %:   -2,092.24%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy